91 related articles for article (PubMed ID: 11778285)
1. [Biotherapy and biochemotherapy of patients with malignant melanoma].
Li Y; Qu F; Li J
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):430-1. PubMed ID: 11778285
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
[TBL] [Abstract][Full Text] [Related]
3. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
Lewis KD; Robinson WA; McCarter M; Pearlman N; O'Day SJ; Anderson C; Amatruda TT; Baron A; Zeng C; Becker M; Dollarhide S; Matijevich K; Gonzalez R
J Clin Oncol; 2006 Jul; 24(19):3157-63. PubMed ID: 16809738
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
5. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
Bedikian AY; Johnson MM; Warneke CL; McIntyre S; Papadopoulos N; Hwu WJ; Kim K; Hwu P
J Immunotoxicol; 2008 Apr; 5(2):201-7. PubMed ID: 18569391
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.
Neri B; Vannozzi L; Fulignati C; Pantaleo P; Pantalone D; Paoletti C; Perfetto F; Turrini M; Mazzanti R
Cancer Invest; 2006; 24(5):474-8. PubMed ID: 16939954
[TBL] [Abstract][Full Text] [Related]
7. Determinants of outcome in melanoma patients with cerebral metastases.
Fife KM; Colman MH; Stevens GN; Firth IC; Moon D; Shannon KF; Harman R; Petersen-Schaefer K; Zacest AC; Besser M; Milton GW; McCarthy WH; Thompson JF
J Clin Oncol; 2004 Apr; 22(7):1293-300. PubMed ID: 15051777
[TBL] [Abstract][Full Text] [Related]
8. [Anorectal malignant melanoma: report of 33 cases].
Liu J; Zhang L; Zeng X
Zhonghua Wai Ke Za Zhi; 1996 Nov; 34(11):665-7. PubMed ID: 9590754
[TBL] [Abstract][Full Text] [Related]
9. Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study.
Ganly I; Patel SG; Singh B; Kraus DH; Bridger PG; Cantu G; Cheesman A; De Sa G; Donald P; Fliss DM; Gullane P; Janecka I; Kamata SE; Kowalski LP; Levine PA; Medina dos Santos LR; Pradhan S; Schramm V; Snyderman C; Wei WI; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):73-8. PubMed ID: 16415433
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
Gibbs P; Anderson C; Pearlman N; LaClaire S; Becker M; Gatlin K; O'Driscoll M; Stephens J; Gonzalez R
Cancer; 2002 Jan; 94(2):470-6. PubMed ID: 11900232
[TBL] [Abstract][Full Text] [Related]
12. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
[TBL] [Abstract][Full Text] [Related]
13. Biochemotherapy in patients with advanced head and neck mucosal melanoma.
Bartell HL; Bedikian AY; Papadopoulos NE; Dett TK; Ballo MT; Myers JN; Hwu P; Kim KB
Head Neck; 2008 Dec; 30(12):1592-8. PubMed ID: 18798304
[TBL] [Abstract][Full Text] [Related]
14. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?
Hofmann MA; Sterry W; Trefzer U
Jpn J Clin Oncol; 2007 Mar; 37(3):224-9. PubMed ID: 17472972
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
Knorr C; Meyer T; Janssen T; Goehl J; Hohenberger W
Eur J Surg Oncol; 2006 Mar; 32(2):224-7. PubMed ID: 16289716
[TBL] [Abstract][Full Text] [Related]
16. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
Eisen T; Thomas J; Miller WH; Gore M; Wolter P; Kavan P; MartÃn JA; Lardelli P
Melanoma Res; 2009 Jun; 19(3):185-92. PubMed ID: 19436178
[TBL] [Abstract][Full Text] [Related]
18. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy for primary mucosal melanoma of the head and neck.
Temam S; Mamelle G; Marandas P; Wibault P; Avril MF; Janot F; Julieron M; Schwaab G; Luboinski B
Cancer; 2005 Jan; 103(2):313-9. PubMed ID: 15578718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
